Cargando…

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant

Since the COVID-19 pandemic began, different SARS-CoV-2 variants have been identified and associated with higher transmissibility than the ancestral nonvariant strain. During January 1, 2021–January 15, 2022, we assessed differences in clinical and viral parameters in a convenience sample of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintero, Ana Maria, Eisner, Mariah, Sayegh, Rouba, Wright, Tori, Ramilo, Octavio, Leber, Amy L., Wang, Huanyu, Mejias, Asuncion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622241/ https://www.ncbi.nlm.nih.gov/pubmed/36285986 http://dx.doi.org/10.3201/eid2811.220577

Ejemplares similares

Prevalence, Genotypes, Clinical Manifestations and Outcomes Associated with Human Parechovirus (HPeV) Infections in Infants up to 2 Months old in Central Ohio
por: Souverbielle, Cristina Tomatis, et al.
Publicado: (2017)

Viral Loads and Disease Severity in Children with Rhinovirus-Associated Illnesses
por: Sanchez-Codez, Maria I., et al.
Publicado: (2021)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

Year-Round, Routine Testing of Multiple Body Site Specimens for Human Parechovirus in Young Febrile Infants
por: Tomatis Souverbielle, Cristina, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
por: Bline, Katherine, et al.
Publicado: (2022)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

Mycoplasma pneumoniae Macrolide Resistance in Children in Central Ohio Detected by Sequencing
por: Lanata Piazzon, Mariana, et al.
Publicado: (2017)

2337. Clinical Characteristics of Children Infected With Macrolide-Resistant Mycoplasma Pneumonia in Central Ohio—Preliminary Data
por: Piazzon, Mariana Lanata, et al.
Publicado: (2018)

Enterovirus D68 in Hospitalized Children: Sequence Variation, Viral Loads and Clinical Outcomes
por: Moyer, Katherine, et al.
Publicado: (2016)

Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021)

999. Nasal Mucosal Cytokines: Potential Biomarkers for Pediatric Pneumonia Severity and Etiology
por: Sayegh, Rouba, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
por: Lanata, Mariana M., et al.
Publicado: (2021)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

1624. SARS-CoV-2 Maternal Vaccination Induces More Efficient Placental Antibody Transfer to Newborns than SARS-CoV-2 Infection During Pregnancy
por: Latorre, Leire Pérez, et al.
Publicado: (2023)

2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
por: Wook Yun, Ki, et al.
Publicado: (2019)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

1138 Human Adenovirus (HAdV) Blood Viral Detection is Associated with Higher Viral Load in Immunocompetent Pediatric HAdV Respiratory Samples
por: Song, Eunkyung, et al.
Publicado: (2014)

The importance of viral testing in infants and young children with bronchiolitis()
por: Mejias, Asuncion, et al.
Publicado: (2022)

2854. Enterovirus D68 Infections in Pediatric Patients in Central Ohio: Clinical Characteristics of a New Outbreak in 2018
por: Diaz, Alejandro, et al.
Publicado: (2019)

Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
por: Wallihan, Rebecca G., et al.
Publicado: (2018)

Impact of Enterovirus D68 in Children With Asthma and Other Complex Medical Conditions
por: Moyer, Katherine, et al.
Publicado: (2015)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults
por: Suarez, Nicolas M., et al.
Publicado: (2015)

Respiratory Syncytial Virus bronchiolitis: Impact of second-hand smoke exposure on immune profiles
por: Diaz, Alejandro, et al.
Publicado: (2017)

118 Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV)
por: Jaggi, Preeti, et al.
Publicado: (2014)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
por: Brenes-Chacon, Helena, et al.
Publicado: (2020)

Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections
por: Banchereau, Romain, et al.
Publicado: (2012)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-2
por: Wang, Huanyu, et al.
Publicado: (2022)

204. Mucosal Cytokine Profiles in Children with COVID-19
por: Cohen, Shira H, et al.
Publicado: (2021)

A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience
por: Vicetti Miguel, Claudia P., et al.
Publicado: (2019)

Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018
por: Wang, Huanyu, et al.
Publicado: (2019)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations
por: Nouri, Nima, et al.
Publicado: (2023)

Neurotropism of SARS-CoV 2: Mechanisms and manifestations
por: Conde Cardona, Giancarlos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ev8p3p923i099qqmemb5t9kamt